Concepedia

Holly Bazmi

HB

Statistics

Publications

8

Citations

2.1K

H-Index

8

Active since

1993

Affiliations

University of Pittsburgh(Current)

National Institute of Allergy and Infectious Diseases

Emory University

Veterans Health Administration

University of Pittsburgh Medical Center

Holly Bazmi is an author at University of Pittsburgh specializing in antiretroviral therapy, life sciences, and molecular virology.

Publications per year

1993–2005

8

Publications

8

New Real-Time Reverse Transcriptase-Initiated PCR Assay with Single-Copy Sensitivity for Human Immunodeficiency Virus Type 1 RNA in Plasma

Sarah Palmer, Ann Wiegand, Frank Maldarelli et al. · Journal of Clinical Microbiology · 2003 · 611 citations · Full text

, , +12

Multiple, Linked Human Immunodeficiency Virus Type 1 Drug Resistance Mutations in Treatment-Experienced Patients Are Missed by Standard Genotype Analysis

Sarah Palmer, Mary F. Kearney, Frank Maldarelli et al. · Journal of Clinical Microbiology · 2005 · 511 citations · Full text

, , +15

Characterization of human immunodeficiency viruses resistant to oxathiolane-cytosine nucleosides

Raymond F. Schinazi, Robert M. Lloyd, M. Hong Nguyen et al. · Antimicrobial Agents and Chemotherapy · 1993 · 367 citations

, , +14

Natural History of Human Immunodeficiency Virus Type 1 Viremia after Seroconversion and Proximal to AIDS in a Large Cohort of Homosexual Men

Robert H. Lyles, Álvaro Muñoz, Traci E. Yamashita et al. · The Journal of Infectious Diseases · 2000 · 356 citations · Full text

, , +16

In Vitro Selection of Mutations in the Human Immunodeficiency Virus Type 1 Reverse Transcriptase That Decrease Susceptibility to (−)-β- <scp>d</scp> -Dioxolane-Guanosine and Suppress Resistance to 3′-Azido-3′-Deoxythymidine

Holly Bazmi, Jennifer Hammond, Sócrates C.H. Cavalcanti et al. · Antimicrobial Agents and Chemotherapy · 2000 · 99 citations · Full text

, , +16

1–5 of 8